Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome
- PMID: 2968116
- DOI: 10.1111/j.1471-0528.1988.tb06601.x
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome
Abstract
Second trimester maternal serum unconjugated oestriol levels were measured in the stored serum samples from 22 pregnancies associated with Down's syndrome and 110 unaffected control pregnancies, matched for maternal age, gestational age, duration of storage of the serum sample, smoking habits and maternal weight. The serum unconjugated oestriol level of each affected pregnancy was expressed as a multiple of the median (MoM) of its five matched controls. The unconjugated oestriol levels were significantly lower in the affected pregnancies than in the unaffected pregnancies; the median MoM was 0.79 (P less than 0.05). This association between low serum unconjugated oestriol and fetal Down's syndrome early in pregnancy raises the possibility that serum unconjugated oestriol measurement may be added to maternal age and alpha-fetoprotein measurement in the antenatal screening for Down's syndrome.
Similar articles
-
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome.Br J Obstet Gynaecol. 1988 Apr;95(4):334-41. doi: 10.1111/j.1471-0528.1988.tb06602.x. Br J Obstet Gynaecol. 1988. PMID: 2454652
-
Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.Hum Reprod. 1998 Jan;13(1):220-3. doi: 10.1093/humrep/13.1.220. Hum Reprod. 1998. PMID: 9512261 Clinical Trial.
-
Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.Br J Obstet Gynaecol. 1992 Jan;99(1):51-3. doi: 10.1111/j.1471-0528.1992.tb14392.x. Br J Obstet Gynaecol. 1992. PMID: 1372176
-
Maternal serum markers for Down's syndrome pregnancies.Singapore Med J. 1995 Aug;36(4):417-23. Singapore Med J. 1995. PMID: 8919160 Review.
-
Antenatal screening for Down's syndrome.J Med Screen. 1997;4(4):181-246. doi: 10.1177/096914139700400402. J Med Screen. 1997. PMID: 9494915 Review.
Cited by
-
Second trimester serum tests for Down's Syndrome screening.Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD009925. doi: 10.1002/14651858.CD009925. Cochrane Database Syst Rev. 2012. PMID: 22696388 Free PMC article.
-
Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta.Int J Mol Sci. 2023 Apr 21;24(8):7669. doi: 10.3390/ijms24087669. Int J Mol Sci. 2023. PMID: 37108840 Free PMC article. Review.
-
Integration of molecular diagnostics and karyotyping for enhanced detection of chromosomal abnormalities in fetuses.Arch Med Sci. 2025 Jun 25;21(3):1062-1068. doi: 10.5114/aoms/205110. eCollection 2025. Arch Med Sci. 2025. PMID: 40741248 Free PMC article. No abstract available.
-
The effect of a vanishing twin on first- and second-trimester maternal serum markers and ultrasound screening for aneuploidy.Obstet Gynecol Sci. 2023 Nov;66(6):477-483. doi: 10.5468/ogs.22270. Epub 2023 Aug 2. Obstet Gynecol Sci. 2023. PMID: 37532226 Free PMC article.
-
Pregnancy associated plasma protein-A2: a novel biomarker for Down syndrome.Placenta. 2014 Nov;35(11):900-6. doi: 10.1016/j.placenta.2014.08.001. Epub 2014 Aug 12. Placenta. 2014. PMID: 25154785 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical